Smarter Solutions for a Healthier Life
Duopharma leads the way to provide quality and innovative healthcare products
All products manufactured by Duopharma Biotech are halal
Beyond making the right choices about diet, exercise, and adequate sleep – supporting the immune system through supplements has shown to help people defend against many health threats.
The search for staying our healthiest is ever-growing. More people are looking to product manufacturers to create supplement products that can help them be well and stay well, particularly by boosting their immune system.
Enter Duopharma
Malaysian company Duopharma Biotech Group is striving to produce health products of global standards for people all around the world.
Duopharma Biotech Group began with the establishment of Duopharma (M) Sendirian Berhad in 1979. Duopharma Biotech was incorporated in 2000 and is today one of Malaysia's leading pharmaceutical companies listed on the Main Market of Bursa Malaysia Berhad.
Duopharma Biotech has core competencies in the pharmaceutical industry inclusive of Manufacturing, Research & Development and Commercialisation & Marketing.
Headquartered in Kuala Lumpur, Malaysia, Duopharma Biotech owns and operates three Malaysian manufacturing plants in Klang, Bangi and Glenmarie, Selangor. Duopharma Biotech also has subsidiary companies in the Philippines and Singapore. A subsidiary of Duopharma Biotech Berhad has a representative office in Jakarta, Indonesia.
Bestsellers ... Flavettes Effervescent (Vitamin C)
Winning Products
Over the years, the company have marketed over 300 generic drugs include Omesec and Prelica as well as consumer healthcare products including Champs, Flavettes, Proviton and Uphamol.
These products are well-recognised and accepted by consumers in Malaysia, regionally and also globally.
In Malaysia, Duopharma is a market leader in Vitamin C products via the Flavettes and Champs brands.
Entering Halal Market
Furthermore, the pharma outfit is continuing to expand its halal portfolio to distinguish itself from its competitors.
Its motivation in the halal pharmaceutical segment is driven by the vast business potential it presents. It also provides discerning consumers with peace of mind, knowing they can obtain quality, halal-certified medication.
The company has also achieved MS2424:2019, the first halal pharmaceutical standard in the world – strengthening its position as the industry leader in the halal space. All products manufactured by Duopharma Biotech are halal.
Besides, the halal certification from the Korean Muslim Federation for its Erysaa drug (biosimilar erythropoietin) marks a significant milestone for the company. It is the first biosimilar drug to receive halal certification anywhere in the world.
Future Plans
Biotech aspires to be one of the largest regional players in South East Asia with a solid presence in international markets. The company continues to implement the strategy for growth in the space of niche biosimilars, regenerative therapeutics, speciality range of products – underpinned with halal certification as its differentiator.
The company is also working on a pipeline of products that will address various prevalent therapeutic conditions and will enable it to continue in providing good treatment options.
Furthermore, Duopharma Biotech has started to embark on the use of digital applications and tools to complement its therapeutics, especially in the speciality ethical products.
Contact Us
DUOPHARMA BIOTECH BERHAD
Suite 18.06, Level 18, Kenanga International, No. 26, Jalan Sultan Ismail, 50250 Kuala Lumpur, Malaysia
Tel: +603-2162 0218
Fax: +603-2161 0507
Contact: Ms Nor Soleha Ab Shukor
